Company intelligence / Profile preview

Gehl

Chicago, Illinois, United Statesgehl.com ↗

Ownership: Private
Employees: ~50000
Development stage: Commercial

Overview

GE HealthCare provides integrated medical technologies, digital solutions, diagnostic imaging agents, and advanced biomanufacturing capabilities. It operates globally with a focus on precision health. Its former BioPharma division was sold to Danaher in 2019. The company continues to innovate in radiopharmaceuticals and molecular imaging while supporting bioprocessing for biologics and gene therapies.

Modalities: BiologicSmall moleculeRadiopharmaceuticalGene therapy (manufacturing support)Monoclonal antibody (manufacturing support)Viral vector (manufacturing support)Device
Industry: Medical Imaging

Partnerships

Cleanroom Combination Group (CCG) for GMP facility expansion in Netherlands

Beyond the preview

Go deeper on Gehl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gehl.

Explore the full profile